Table 4.
CD34+ |
CD34+/KDR+ |
CFU |
||||
---|---|---|---|---|---|---|
β (SE) | P | β (SE) | P | β (SE) | P | |
Flow-mediated dilation, % | −0.057 (0.073) | 0.44 | −0.034 (0.070) | 0.63 | −0.020 (0.069) | 0.77 |
Hyperemic flow velocity, cm/s | −0.332 (0.535) | 0.53 | −0.573 (0.521) | 0.27 | −0.021 (0.531) | 0.97 |
PAT ratio, unitless | −0.023 (0.010) | 0.03 | −0.017 (0.010) | 0.09 | 0.006 (0.010) | 0.58 |
Carotid-femoral pulse wave velocity, m/s | −0.003 (0.072) | 0.97 | −0.059 (0.071) | 0.41 | 0.128 (0.072) | 0.07 |
Carotid-brachial pulse wave velocity, m/s | 0.075 (0.040) | 0.06 | 0.067 (0.039) | 0.08 | 0.072 (0.038) | 0.06 |
Regression coefficients represent difference in the vascular measure per 1-SD difference in log CD34+, log CD34+/KDR+, and square-root CFU. All analyses are adjusted for age, sex, systolic blood pressure, diastolic blood pressure, body mass index, total/HDL cholesterol ratio, triglycerides, glucose, diabetes mellitus, smoking, hypertension medication, lipid-lowering treatment, hormone-replacement therapy, prevalent CVD.